MAI Wealth Advisors »

Cidara Therapeutics shares owned by MAI Wealth Advisors

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by MAI Wealth Advisors from 13F filings

Historical chart of MAI Wealth Advisors investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by MAI Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by MAI Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $670 7 95.86

More positions owned by MAI Wealth Advisors

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple Call Call Option (Principal) (AAPL)
Microsoft Corp Call Call Option (Principal) (MSFT)
Ishares Tr Core S&p Mcp Etf (IJH)
Nvidia Corporation Call Call Option (Principal) (NVDA)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p Scp Etf (IJR)
Amazon Call Call Option (Principal) (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr S&p 500 Val Etf (IVE)
Broadcom Call Call Option (Principal) (AVGO)
Alphabet Call Call Option (Principal) (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for MAI Wealth Advisors

Top funds holding Cidara Therapeutics

RA Capital Management
Bain Capital Life Sciences Investors
Point72 Asset Management
BVF
Vivo Capital
Vanguard Group
BlackRock
Darwin Global Management
Paradigm Biocapital Advisors
VR Adviser
Morgan Stanley
FMR
State Street Corporation
Citadel Advisors
Henderson Group

View all funds holding Cidara Therapeutics